Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

189.84 +3.23 (+1.73%)
Official Closing Price Updated: 4:10 PM EDT, May 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Tesla To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
This Boeing Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Quest Diagnostics? ↗
 
Via Benzinga
News headline image
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S. 
Via News Direct
News headline image
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services ↗
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending. 
Via Benzinga
News headline image
The Analyst Landscape: 8 Takes On Quest Diagnostics ↗
 
Via Benzinga
News headline image
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA Approval 
From Mainz BioMed NV
Via GlobeNewswire
News headline image
Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗
 
Via Benzinga
News headline image
(DGX) - Analyzing Quest Diagnostics's Short Interest ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Quest Diagnostics? ↗
 
Via Benzinga
News headline image
What Analysts Are Saying About Quest Diagnostics Stock ↗
 
Via Benzinga
News headline image
Cracking The Code: Understanding Analyst Reviews For Quest Diagnostics ↗
 
Via Benzinga
News headline image
Guardant Health Stock Sees RS Rating Jump To 83 ↗
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. 
Via Investor's Business Daily
News headline image
Navigating Earnings Season: Weather Any Storm ↗
The consequences of hurricanes like Helene and Milton are—typically—quickly shrugged aside by markets as one-off events. That is mostly correct. But not entirely so. For some companies, the revenue and... 
Via Talk Markets
News headline image
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare ↗
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
News headline image
Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact ↗
LabCorp Q3 2024 EPS beats expectations at $3.50, with 7.4% revenue growth to $3.28B. Adjusted EPS guidance revised due to weather. 
Via Benzinga
Topics Earnings
News headline image
Earnings Preview: Quest Diagnostics ↗
 
Via Benzinga
News headline image
Looking Into Quest Diagnostics's Recent Short Interest ↗
 
Via Benzinga
News headline image
Decoding 7 Analyst Evaluations For Quest Diagnostics ↗
 
Via Benzinga
News headline image
What Analysts Are Saying About Quest Diagnostics Stock ↗
 
Via Benzinga
News headline image
This Snap Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗
 
Via Benzinga
News headline image
Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025 ↗
Quest Diagnostics reports strong Q3 with 8.5% sales growth, raises 2024 revenue guidance to $9.80 billion-$9.85 billion, citing acquisitions and new customer wins. 
Via Benzinga
News headline image
Uber To Rally Over 33%? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain ↗
Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing... 
Via Benzinga
News headline image
Uncovering Dividend Opportunities with NYSE:DGX. ↗
Analyzing QUEST DIAGNOSTICS INC (NYSE:DGX)'s Dividend Potential. 
Via Chartmill
News headline image
5 Analysts Assess Quest Diagnostics: What You Need To Know ↗
 
Via Benzinga
News headline image
8 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector ↗
LabCorp reported Q2 2024 adjusted EPS of $3.94, surpassing expectations of $3.78. Sales increased by 6.2% to $3.22 billion, driven by organic revenue growth and acquisitions. LabCorp revised its 2024... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.